Karnataka govt flags 14 substandard drugs; tells chemists, docs, public to avoid them
'In case they hold any stock, they are requested to inform the concerned area Drugs Inspector or Assistant Drugs Controller. The public is also advised not to use these drugs or cosmetics,' the statement added. The substandard drugs include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals; Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536) and MITO Q7 Syrup by Bion Therapeutics India (batch no: CHS-40170) among others. The department has urged strict compliance with these directions to safeguard public health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
12 hours ago
- New Indian Express
All Ayush medicines now to be brought under FDA: Karnataka Health Minister Dinesh Gundu Rao
BENGALURU: Karnataka Health Minister Dinesh Gundu Rao said on Monday that all medicines under the Department of Ayush, including those in Ayurvedic, Unani, Siddha, and Homeopathy streams, will now be brought under the drugs control wing of the Food Safety and Drug Administration (FDA). Addressing reporters here, he said this is specifically to improve the quality of traditional medicines. He said the Health Department has reduced the time it took to recall substandard medicines from the market. Earlier, once a drug was flagged as Not of Standard Quality (NSQ), it could take up to 30 days to take it back from pharmacies and distributors. Now, that time has been cut to just two days. Rao said this is crucial because such medicines, if left on shelves, may continue to be taken by patients, posing serious health risks. In June alone, drugs worth Rs 40.48 lakh that did not meet the safety standards were recalled and seized across the state. The department noted that in July, 1,433 drug samples were analysed by laboratories in Bengaluru, Hubballi and Ballari. Of them, 67 were found to be substandard with the department filing 29 cases. A special enforcement drive was held on June 24 and 25, during which 279 inspections were conducted at drug stores across the state. During the drive, 231 show cause notices were issued to offending establishments. In all, 15 compliance notices were served, Rao said. On digitisation of services, the minister said all applications related to blood centres are now processed through the Online National Drugs Licensing System (ONDLS) portal, with licenses issued exclusively online. In addition, an online platform has been launched to issue Recognised Medical Institution (RMI) certificates required by institutions authorised to handle essential narcotic drugs. Food samples In July, 1,557 street food vendors were inspected. Items such as fruits, vegetables, water bottles, bakery products and spice powders were checked. Of them, 406 violated safety norms. Spot fines amounting to Rs 44,500 were collected from the violators. At 186 bus stations across the state, 889 food stalls were inspected. Of them, 206 violated safety norms. Rao said as part of the drive, the department collected six samples of kebab from Empire Restaurant and all contained banned colours, including Sunset Yellow. He said the restaurant is now serving kebabs without colours. The minister also urged people to seek good quality food and report cases where they find eateries serving artificially coloured food items.
NDTV
2 days ago
- NDTV
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies. The formulations, which will now cost less, span a wide range of medicines including anti-inflammatory, cardiovascular, antibiotic, anti-diabetic and psychiatric medicines. The Ministry of Chemicals and Fertilisers notified the order based on price regulation by the NPPA. The price reductions, which apply across drugs, are expected to bring relief to consumers, particularly those managing chronic conditions. The key formulations covered by the price control order include fixed-dose combinations of Aceclofenac, Paracetamol and Trypsin Chymotrypsin, Amoxycillin and Potassium Clavulanate, Atorvastatin combinations and newer oral anti-diabetic combinations like Empagliflozin, Sitagliptin, and Metformin. The price of one Aceclofenac-Paracetamol-Trypsin Chymotrypsin tablet manufactured by Akums Drugs & Pharmaceuticals and marketed by Dr Reddy's Laboratories has now been fixed at Rs 13, while the same formulation marketed by Cadila Pharmaceuticals is now priced at Rs 15.01. Similarly, a tablet containing Atorvastatin 40 mg and Clopidogrel 75 mg, widely used for cardiovascular conditions, is priced at Rs 25.61. Oral suspensions for paediatric use - Cefixime and Paracetamol combinations - have also been included, along with critical medications like Cholecalciferol drops for Vitamin D supplementation and Diclofenac Injection, which has been priced at Rs 31.77 per ml. The official order states that retailers and dealers must display these updated price lists prominently in their premises. Failure to comply with the notified prices may attract penal provisions under the DPCO, 2013, and the Essential Commodities Act, 1955, including recovery of overcharged amounts with interest. The NPPA clarified that the prices fixed were exclusive of Goods and Services Tax (GST), which may be added, if applicable. Manufacturers are required to comply with all statutory requirements, issue updated price lists in Form V through the Integrated Pharmaceutical Database Management System and submit the information to the NPPA and state drug controllers. Any prior price orders issued for the specified formulations and manufacturers stand superseded by this latest notification. The NPPA, which functions under the Ministry of Chemicals and Fertilisers, is the drug price regulator in India, responsible for fixing and revising prices of pharmaceutical products and monitoring the prices of both controlled and decontrolled drugs.
The Hindu
5 days ago
- The Hindu
Karnataka Food Safety and Drug Administration shifts focus to trans fat reduction in cooking oil
After a crackdown on food additives, the State Food Safety and Drug Administration has now turned its attention towards tackling trans fat in cooking oil, with a focus on improving public health and food safety. In a video conference, chaired by the Commissioner of Food Safety and Drug Administration on Wednesday, key stakeholders, including district officials, hotel and bakery association representatives, RUCO (Repurpose Used Cooking Oil) agency heads, and members of the Karnataka State Bio-Diesel Development Board, gathered to discuss a multi-pronged strategy. Hygiene and labelling The commissioner directed all cooking oil manufacturers to ensure strict hygiene in production, proper labelling per FSSAI norms, and mandatory fortification of cooking oil with Vitamin A and D. Manufacturers were also advised to conduct oil quality analysis every six months to ensure compliance. U.S. Vishal Rao, oncologist and head and neck surgeon at HCG Cancer Centre, joined the meeting virtually and stressed the importance of using cooking oils with reduced trans fat. He highlighted the link between trans fat and non-communicable diseases such as heart disease and cancer, urging the food industry to adopt healthier practices. RUCO agency representatives informed the commissioner that 32.68 lakh litres of used cooking oil had been collected during 2024-25 and 2025-26. Agencies were encouraged to ramp up collection efforts and supply the used oil to authorised bio-diesel units. Preventing reuse Strict instructions were issued to hotel and bakery operators to hand over used oil to registered RUCO agencies to prevent its reuse — a practice that poses serious health risks. The food safety commissioner reiterated the administration's commitment to building a safer and healthier food ecosystem in Karnataka, with the reduction of trans fat and proper oil disposal emerging as key priorities.
